The key facts regarding predicting future ILI occurrence can be summarized as follows:

1. Influenza activity remains low in the United States.

2. The percentage of respiratory specimens testing positive for influenza in clinical labs is 0.1%, and the majority of positive specimens are Influenza A.

3. Outpatient visits for ILI are below the national baseline of 2.5%, with 1.9% of visits attributed to ILI.

4. Geographic spread of influenza shows minimal activity in most areas, with some regions experiencing moderate activity.

5. Hospitalization rates and pediatric deaths from influenza are not reported for the current season.

6. The influenza vaccine is recommended for everyone 6 months and older, and antiviral drugs can be used to treat influenza illness.

7. Virologic surveillance, including virus characterization, helps monitor the circulating influenza viruses and their resistance to antiviral medications.

8. The National Center for Health Statistics reports that 18.0% of deaths in week 40 were attributed to pneumonia, influenza, or COVID-19, above the epidemic threshold.

9. Up-to-date influenza surveillance information can be accessed through various national and international organizations, such as WHO and Public Health Agency of Canada.

10. The CDC's influenza surveillance system provides comprehensive data components and methodologies for monitoring influenza activity.